CLINICAL_TRIALS ClinicalTrials.gov record update

Comparing Anti-XA Levels in Post-Cesarean Patients With BMI >35 Undergoing Enoxaparin Thromboprophylaxis With Weight Based Dosing Twice Daily Versus Fixed Dose 40 Milligrams Daily

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02070237
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:04.343260+00:00
Published At: 2015-11-23T00:00:00+00:00
Record Updated At: 2015-11-23
Results Posted At: 2015-11-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Obesity", "Obesity, Morbid", "Pregnancy", "Complications; Cesarean Section", "Venous Thromboembolism", "Postpartum Deep Phlebothrombosis", "Pulmonary Embolism"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2015-11-23"
protocolSection.identificationModule.nctId: "NCT02070237"
protocolSection.identificationModule.officialTitle: "Comparing Anti-XA Levels in Post-Cesarean Patients With BMI \u003e35 Undergoing Enoxaparin Thromboprophylaxis With Weight Based Dosing Twice Daily Versus Fixed Dose 40 Milligrams Daily"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2015-11-23"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.